<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33785495</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.</ArticleTitle><Pagination><StartPage>e048391</StartPage><MedlinePgn>e048391</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e048391</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-048391</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To assess medium-term organ impairment in symptomatic individuals following recovery from acute SARS-CoV-2 infection.</AbstractText><AbstractText Label="DESIGN">Baseline findings from a prospective, observational cohort study.</AbstractText><AbstractText Label="SETTING">Community-based individuals from two UK centres between 1 April and 14 September 2020.</AbstractText><AbstractText Label="PARTICIPANTS">Individuals &#x2265;18 years with persistent symptoms following recovery from acute SARS-CoV-2 infection and age-matched healthy controls.</AbstractText><AbstractText Label="INTERVENTION">Assessment of symptoms by standardised questionnaires (EQ-5D-5L, Dyspnoea-12) and organ-specific metrics by biochemical assessment and quantitative MRI.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Severe post-COVID-19 syndrome defined as ongoing respiratory symptoms and/or moderate functional impairment in activities of daily living; single-organ and multiorgan impairment (heart, lungs, kidneys, liver, pancreas, spleen) by consensus definitions at baseline investigation.</AbstractText><AbstractText Label="RESULTS">201 individuals (mean age 45, range 21-71 years, 71% female, 88% white, 32% healthcare workers) completed the baseline assessment (median of 141 days following SARS-CoV-2 infection, IQR 110-162). The study population was at low risk of COVID-19 mortality (obesity 20%, hypertension 7%, type 2 diabetes 2%, heart disease 5%), with only 19% hospitalised with COVID-19. 42% of individuals had 10 or more symptoms and 60% had severe post-COVID-19 syndrome. Fatigue (98%), muscle aches (87%), breathlessness (88%) and headaches (83%) were most frequently reported. Mild organ impairment was present in the heart (26%), lungs (11%), kidneys (4%), liver (28%), pancreas (40%) and spleen (4%), with single-organ and multiorgan impairment in 70% and 29%, respectively. Hospitalisation was associated with older age (p=0.001), non-white ethnicity (p=0.016), increased liver volume (p&lt;0.0001), pancreatic inflammation (p&lt;0.01), and fat accumulation in the liver (p&lt;0.05) and pancreas (p&lt;0.01). Severe post-COVID-19 syndrome was associated with radiological evidence of cardiac damage (myocarditis) (p&lt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS">In individuals at low risk of COVID-19 mortality with ongoing symptoms, 70% have impairment in one or more organs 4&#x2009;months after initial COVID-19 symptoms, with implications for healthcare and public health, which have assumed low risk in young people with no comorbidities.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT04369807; Pre-results.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dennis</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wamil</LastName><ForeName>Malgorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Great Western Hospital Foundation NHS Trust, Swindon, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberts</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Alliance Medical, Warwick, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oben</LastName><ForeName>Jude</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Liver and Digestive Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuthbertson</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wootton</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Research, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crooks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical and Applied Health Research, University of Hull, Hull, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabbay</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hishmeh</LastName><ForeName>Lyth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Long COVID SOS, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attree</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UKDoctors#Longcovid, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Rajarshi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Perspectum, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University College London Hospitals NHS Foundation Trust, London, UK ami.banerjee@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COVERSCAN study investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04369807</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055812" MajorTopicYN="N">Community-Based Participatory Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">health policy</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>Competing interests: AD, RB and MB are employees of Perspectum.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33785495</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pii">bmjopen-2020-048391</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. interim guidance 13 March 2020, 2020. Available: https://apps.who.int/iris/handle/10665/331446
</Citation></Reference><Reference><Citation>Pavon AG, Meier D, Samim D, et al. . First documentation of persistent SARS-Cov-2 infection presenting with late acute severe myocarditis. Can J Cardiol 2020;36:1326.e5&#x2013;1326.e7. 10.1016/j.cjca.2020.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.06.005</ArticleId><ArticleId IdType="pmc">PMC7834643</ArticleId><ArticleId IdType="pubmed">32522523</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2019;2020:1265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabary M, Khanmohammadi S, Araghi F, et al. . Pathologic features of COVID-19: a Concise review. Pathol Res Pract 2020;216:153097. 10.1016/j.prp.2020.153097</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2020.153097</ArticleId><ArticleId IdType="pmc">PMC7334952</ArticleId><ArticleId IdType="pubmed">32825963</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: the current evidence. United European Gastroenterol J 2020;8:509&#x2013;19. 10.1177/2050640620924157</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050640620924157</ArticleId><ArticleId IdType="pmc">PMC7268949</ArticleId><ArticleId IdType="pubmed">32450787</ArticleId></ArticleIdList></Reference><Reference><Citation>Somasundaram NP, Ranathunga I, Ratnasamy V, et al. . The impact of SARS-Cov-2 virus infection on the endocrine system. J Endocr Soc 2020;4:1&#x2013;22. 10.1210/jendso/bvaa082</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvaa082</ArticleId><ArticleId IdType="pmc">PMC7337839</ArticleId><ArticleId IdType="pubmed">32728654</ArticleId></ArticleIdList></Reference><Reference><Citation>Farouk SS, Fiaccadori E, Cravedi P, et al. . COVID-19 and the kidney: what we think we know so far and what we don't. J Nephrol 2020;33:1213&#x2013;8. 10.1007/s40620-020-00789-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-020-00789-y</ArticleId><ArticleId IdType="pmc">PMC7370875</ArticleId><ArticleId IdType="pubmed">32691342</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai A, Pasea L, Banerjee A. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. BMJ Open 2020;10:e043828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674020</ArticleId><ArticleId IdType="pubmed">33203640</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Pasea L, Harris S, et al. . Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet 2020;395:1715&#x2013;25. 10.1016/S0140-6736(20)30854-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30854-0</ArticleId><ArticleId IdType="pmc">PMC7217641</ArticleId><ArticleId IdType="pubmed">32405103</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Chen S, Pasea L. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol 2020. 10.1093/eurjpc/zwaa155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwaa155</ArticleId><ArticleId IdType="pmc">PMC7928969</ArticleId><ArticleId IdType="pubmed">33611594</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-Term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. 10.1016/j.eclinm.2020.100683</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton R. Offline: COVID-19 is not a pandemic. The Lancet 2020;396:874. 10.1016/S0140-6736(20)32000-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32000-6</ArticleId><ArticleId IdType="pmc">PMC7515561</ArticleId><ArticleId IdType="pubmed">32979964</ArticleId></ArticleIdList></Reference><Reference><Citation>Shovlin CL, Vizcaychipi MP. Implications for COVID-19 triage from the ICNARC report of 2204 COVID-19 cases managed in UK adult intensive care units. Emerg Med J 2020;37:332&#x2013;3. 10.1136/emermed-2020-209791</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-209791</ArticleId><ArticleId IdType="pubmed">32366619</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. . Features of 20&#x2009;133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985&#x2013;12. 10.1136/bmj.m1985</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584:430&#x2013;6. 10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . The prevalence of long COVID symptoms and COVID-19 complications, 2020. Available: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications
</Citation></Reference><Reference><Citation>del Rio C, Collins LF, Malani P. Long-Term health consequences of COVID-19. JAMA 2020;324:1723. 10.1001/jama.2020.19719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020;370:m3489. 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, et al. . Management of post-acute covid-19 in primary care. BMJ 2020;13:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health Research . New risk prediction model could help improve guidance for people shielding from COVID-19, 2020. Available: https://www.nihr.ac.uk/news/new-risk-prediction-model-could-help-improve-guidance-for-people-shielding-from-covid-19/25096
</Citation></Reference><Reference><Citation>Hill AD, Fowler RA, Pinto R, et al. . Long-term outcomes and healthcare utilization following critical illness &#x2013; a population-based study. Crit Care 2016;20:1&#x2013;10. 10.1186/s13054-016-1248-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1248-y</ArticleId><ArticleId IdType="pmc">PMC4818427</ArticleId><ArticleId IdType="pubmed">27037030</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, et al. . Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses 2020;144:110055. 10.1016/j.mehy.2020.110055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, et al. . Respiratory follow-up of patients with COVID-19 pneumonia. Thorax 2020;75:1009&#x2013;16. 10.1136/thoraxjnl-2020-215314</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang DH, McCoy RG. Planning for the Post-COVID syndrome: how payers can mitigate long-term complications of the pandemic. J Gen Intern Med 2020;35:3036&#x2013;9. 10.1007/s11606-020-06042-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06042-3</ArticleId><ArticleId IdType="pmc">PMC7375754</ArticleId><ArticleId IdType="pubmed">32700223</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen MF, Pickard AS, Golicki D, et al. . Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22:1717&#x2013;27. 10.1007/s11136-012-0322-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-012-0322-4</ArticleId><ArticleId IdType="pmc">PMC3764313</ArticleId><ArticleId IdType="pubmed">23184421</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorke J, Moosavi SH, Shuldham C, et al. . Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65:21&#x2013;6. 10.1136/thx.2009.118521</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.118521</ArticleId><ArticleId IdType="pmc">PMC2795166</ArticleId><ArticleId IdType="pubmed">19996336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobbins A, Barry L, Kelleher D, et al. . The health of the residents of ireland: population norms for Ireland based on the EQ-5D-5L descriptive system &#x2013; a cross sectional study. HRB Open Res 2018;1:22. 10.12688/hrbopenres.12848.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.12848.1</ArticleId><ArticleId IdType="pmc">PMC6973536</ArticleId><ArticleId IdType="pubmed">32002510</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. . Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017&#x2013;32. 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer K, Monaco A, Kivipelto M, et al. . The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res 2020;32:1189&#x2013;94. 10.1007/s40520-020-01601-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01601-4</ArticleId><ArticleId IdType="pmc">PMC7248450</ArticleId><ArticleId IdType="pubmed">32458356</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, et al. . Real-Time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 2020;26:1037&#x2013;40. 10.1038/s41591-020-0916-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill S, et al. . &#x201c;Long-COVID&#x201d;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2020:thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau VQ, Giustino G, Mahmood K, et al. . Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Hear Fail 2020:556&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32844662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, et al. . Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2020:5&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, et al. . Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 2020;369:eabc8511. 10.1126/science.abc8511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, et al. . Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020;369:m1328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>
PHOSP-COVID . Post-HOSPitalisation COVID-19 study, 2020. Available: https://www.phosp.org/
</Citation></Reference><Reference><Citation>
NHS . NHS to offer &#x2018;long covid&#x2019; sufferers help at specialist centres, 2020. Available: https://www.england.nhs.uk/2020/10/nhs-to-offer-long-covid-help/
</Citation></Reference><Reference><Citation>
National Institute for Healh and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2020. Available: https://www.nice.org.uk/guidance/ng188
</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira VM, Piechnik SK, Dall&#x2019;Armellina E, et al. . Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 2014;16:1&#x2013;11. 10.1186/1532-429X-16-36</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-16-36</ArticleId><ArticleId IdType="pmc">PMC4041901</ArticleId><ArticleId IdType="pubmed">24886708</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson LM, Paul L, Chappell FM, et al. . Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis. BMJ 2018;14:k4577. 10.1136/bmj.k4577</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k4577</ArticleId><ArticleId IdType="pmc">PMC6249611</ArticleId><ArticleId IdType="pubmed">30467245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>